HEPION PHARMACEUTICALS, INC. Interest Expense, Related Party
HEPION PHARMACEUTICALS, INC. (HEPA) reported Interest Expense, Related Party of $12.95 thousand for the 12-month period ending 2014-06-30, per its 10-K filed 2015-09-25.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2015-09-25
- HEPION PHARMACEUTICALS, INC. interest expense, related party for the quarter ending 2014-06-30 was -$1.00.
- HEPION PHARMACEUTICALS, INC. interest expense, related party for the quarter ending 2014-03-31 was $6.36K.
- HEPION PHARMACEUTICALS, INC. interest expense, related party for the quarter ending 2013-12-31 was $4.88K.
- HEPION PHARMACEUTICALS, INC. interest expense, related party for the quarter ending 2013-09-30 was $1.71K.
- HEPION PHARMACEUTICALS, INC. interest expense, related party for fiscal 2014 was $12.95K.
| Period end | Interest Expense, Related Party 2 month | Interest Expense, Related Party 3 month | Interest Expense, Related Party 5 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 8 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 11 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $6.35K derived: sum of 2 quarters · filed 2015-09-25 | $11.23K derived: sum of 3 quarters · filed 2015-09-25 | $12.95K 10-K · filed 2015-09-25 | ||||
| 2014-03-31 | $6.36K 10-Q · filed 2015-05-14 | $11.23K derived: sum of 2 quarters · filed 2015-05-14 | $12.95K 10-Q · filed 2015-05-14 | $13.27K 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $4.88K 10-Q · filed 2015-02-12 | $6.59K 10-Q · filed 2015-02-12 | $6.92K 10-Q · filed 2014-02-05 | |||||
| 2013-09-30 | $1.71K 10-Q · filed 2014-11-13 | $2.04K 10-Q · filed 2013-11-19 | ||||||
| 2013-06-30 | $328.00 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |